发明名称 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof
摘要 An optionally N-oxidized compound represented by the formula: wherein R<SUP>1 </SUP>represents hydrogen, hydrocarbon, heterocycle, amino, acyl, R<SUP>2 </SUP>represents an aromatic group, R<SUP>3 </SUP>represents hydrogen, pyridyl, aromatic hydrocarbon, X represents oxygen, optionally oxidized sulfur, Y represents a bond, an oxygen, optionally oxidized sulfur, a group represented by the formula NR<SUP>4 </SUP>(R<SUP>4 </SUP>represents hydrogen, hydrocarbon or acyl) and Z represents a bond or a divalent acyclic hydrocarbon, or a salt thereof has an excellent adenosine A<SUB>3 </SUB>receptor antagonistic activity and is used as an agent for preventing or treating diseases related to an adenosine A<SUB>3 </SUB>receptor. Furthermore, the compound (I) or a salt thereof has p38 MAP kinase inhibitory activity and TNF-alpha inhibitory activity and is used as an agent for preventing or treating diseases related to p38 MAP kinase and diseases related to TNF-alpha.
申请公布号 US7101899(B1) 申请公布日期 2006.09.05
申请号 US20020959356 申请日期 2002.02.07
申请人 TAKEDA PHARMACEUTICAL COMPANY LIMITED 发明人 OHKAWA SHIGENORI;KANZAKI NAOYUKI;MIWATASHI SEIJI
分类号 A61K31/445;A61K31/4439;A61P1/00;A61P3/10;A61P7/00;A61P9/00;A61P29/00;A61P31/12;A61P43/00;C07D417/04;C07D417/14 主分类号 A61K31/445
代理机构 代理人
主权项
地址